Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 72 entries
View as:

A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00005764 Org: User:
Start: 05/31/00 End: - Due: -

Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)

Phase: N/A Priority: Normal
NCT ID: NCT00002026 Org: User:
Start: - End: - Due: -

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

Phase: N/A Priority: Normal
NCT ID: NCT00002048 Org: User:
Start: - End: - Due: -

A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00002284 Org: User:
Start: - End: - Due: -

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00002216 Org: User:
Start: - End: - Due: -

A Study of 1592U89 in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002388 Org: User:
Start: - End: - Due: -

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00004585 Org: User:
Start: 10/31/99 End: - Due: -

A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC

Phase: N/A Priority: Normal
NCT ID: NCT00002046 Org: User:
Start: - End: - Due: -

A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002195 Org: User:
Start: - End: - Due: -

A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

Phase: N/A Priority: Normal
NCT ID: NCT00002423 Org: User:
Start: 03/31/99 End: - Due: -

A Study of a Combination of Four Drugs in Patients With Recent HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00002233 Org: User:
Start: - End: - Due: -

A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications

Phase: N/A Priority: Normal
NCT ID: NCT00002417 Org: User:
Start: - End: - Due: -

Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC

Phase: N/A Priority: Normal
NCT ID: NCT00002020 Org: User:
Start: - End: - Due: -

A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00002086 Org: User:
Start: - End: - Due: -

A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002442 Org: User:
Start: 06/30/99 End: - Due: -

The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System

Phase: N/A Priority: Normal
NCT ID: NCT00002288 Org: User:
Start: - End: - Due: -

A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002084 Org: User:
Start: - End: - Due: -

A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002364 Org: User:
Start: - End: - Due: -

An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00002205 Org: User:
Start: - End: - Due: -

A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX

Phase: N/A Priority: Normal
NCT ID: NCT00002340 Org: User:
Start: - End: - Due: -

The Effect of Teaching HIV-Infected Patients About HIV and Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00002409 Org: User:
Start: - End: - Due: -

Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00002193 Org: User:
Start: - End: - Due: -

A Prospective Double-Blind Study of Retrovir in Early HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00002045 Org: User:
Start: - End: - Due: -

A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002217 Org: User:
Start: - End: - Due: -

A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)

Phase: N/A Priority: Normal
NCT ID: NCT00002014 Org: User:
Start: - End: - Due: -